Friday Center, Chapel Hill, NC
May 13 and 14, 2008

The symposium will focus on the formidable problem of developing new therapies against human malignancies. Topics will range from nanotechnologists discussing novel synthetic methods used to produce revolutionary new anti-cancer molecules to the testing of promising compounds in humans in Phase 1 trials.

Symposium Sponsors

The UNC Lineberger Symposium is able to provide a premier event without charging a registration fee due to the educational grants provided by the following organizations.

Leadership Sponsor ($10,000)

Supporting Sponsors ($5,000 - $9,999)

Associate Sponsor ($2,500 - $4,999)

• Gilead Sciences
• North Carolina Biotechnology Center
• The Hamner Institutes for Health Sciences
• National Institute of Environmental Health Sciences (NIEHS)

Patron ($1,000 - $2,499)

• Applied Biosystems
• Burroughs Wellcome Fund

Friend ($500 - $999)

• ALEXIS Biochemicals
• Invitrogen

Additional Funding Provided by the University Cancer Research Fund.

UNC Chapel Hill Partners

• Biochemistry and Biophysics
• Biology
• Carolina Vaccine Institute
• Cell and Developmental Biology
• Cell and Molecular Physiology
• Dermatology
• Genetics
• Medicine
• Microbiology and Immunology
• Neurology
• Obstetrics and Gynecology
• Pathology and Laboratory Medicine
• Pharmacology
• Radiation Oncology
• Radiology
• Surgery